Agneta Heierson

Corporate Officer/Principal at INFANT BACTERIAL THERAPEUTICS AB

Commercial Services

Health Technology

Profile

Agneta Heierson is currently the Vice President-Clinical Development at Infant Bacterial Therapeutics AB.
She previously worked as the Global VP-Research & Development Supply Chain at AstraZeneca AB.

Agneta Heierson active positions

Companies	Position	Start
INFANT BACTERIAL THERAPEUTICS AB	Corporate Officer/Principal	-

All active positions of Agneta Heierson

Former positions of Agneta Heierson

Companies	Position	End
AstraZeneca AB AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden.	Corporate Officer/Principal	-

See the detail of Agneta Heierson's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Agneta Heierson's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
INFANT BACTERIAL THERAPEUTICS AB	Health Technology

Private companies	1
AstraZeneca AB AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden.	Commercial Services